Skip to content
VLOCMarket desk
Switch to dark mode

유유제약2우B

000227KOSPIView the 제약 sectorTheme Bio & healthcare

7,360KRWMarket close of 10/27 (Tue)

Down -1.47%-110KRWMarket close of 10/27 (Tue)

Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)7,370KRWUp +0.14%

Preliminary · replaced once official KRX data for the same date is published

Open
7,440
High
7,440
Low
7,330
Day range
Day range low 7,330 high 7,440, open 7,440, close 7,360, previous close 7,470
Volume
0×10K shares
3.80 million KRW 0.75× the 20-session average

Market close of 10/27 (Tue)

Where it sits in the 1-year range

1-year close range 6,300 to 11,670 won, 20% up from the low

20% of the way up from the lowest close in 1 year (252 sessions) · -36.9% from the high

Usual range

Nothing unusual in the 4 checked items

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27

Points to check

  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
  • Daily moveusual range-1.47%-1.47%, 1.1× the usual (20-session average ±1.36%)
    That day -1.47% · usual ±1.36% · large-move threshold ±3.0%

The other 2 are within the usual range

  • Trading value0.8×usual range
  • EarningsOperating income, 8 quartersOperating income, 8 quarters
See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue35.5B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +8.0%
    vs. prior quarter
    +3.5%
  • Operating income4.3B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +9.9%
    vs. prior quarter
    Turned profitable
  • Operating margin12.1%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +0.2 pp
    vs. prior quarter
    +12.5 pp

Quarterly operating income trend

2021Q1 456.44 million KRW2026Q1 4.3B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Down -2.22%

· 88 of 168 stocks up, preferred shares excluded · trading value 553.0B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +0.6%Down -5.37%124.5B KRW
셀트리온Close over the last 20 sessions +6.3%Down -0.74%82.4B KRW
지투지바이오Close over the last 20 sessions +22.2%Down -13.38%46.9B KRW
한미약품Close over the last 20 sessions -32.6%Down -0.57%25.5B KRW
에스티팜Close over the last 20 sessions -11.9%Down -9.15%21.4B KRW

Other share classes of this company · 유유제약유유제약1우

Schedule

  • Next data 10/29 (Thu) after 08:50

Related news

All news
Loading

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.